These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 39042672)

  • 1. The CH1 domain influences the expression and antigen sensing of the HIV-specific CH31 IgM-BCR and IgG-BCR.
    Ortiz Y; Anasti K; Kane AP; Cronin K; Alam SM; Reth M
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2404728121. PubMed ID: 39042672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates.
    Hossain MA; Anasti K; Watts B; Cronin K; Derking R; Groschel B; Kane AP; Edwards RJ; Easterhoff D; Zhang J; Rountree W; Ortiz Y; Saunders K; Schief WR; Sanders RW; Verkoczy L; Reth M; Alam SM
    Cell Rep; 2022 Jun; 39(13):111021. PubMed ID: 35767950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.
    Chen Y; Zhang J; Hwang KK; Bouton-Verville H; Xia SM; Newman A; Ouyang YB; Haynes BF; Verkoczy L
    J Immunol; 2013 Aug; 191(3):1260-75. PubMed ID: 23825311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.
    McGuire AT; Gray MD; Dosenovic P; Gitlin AD; Freund NT; Petersen J; Correnti C; Johnsen W; Kegel R; Stuart AB; Glenn J; Seaman MS; Schief WR; Strong RK; Nussenzweig MC; Stamatatos L
    Nat Commun; 2016 Feb; 7():10618. PubMed ID: 26907590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
    Yacoob C; Lange MD; Cohen K; Lathia K; Feng J; Glenn J; Carbonetti S; Oliver B; Vigdorovich V; Sather DN; Stamatatos L
    PLoS Pathog; 2018 Jun; 14(6):e1007120. PubMed ID: 29933399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.
    Godot V; Tcherakian C; Gil L; Cervera-Marzal I; Li G; Cheng L; Ortonne N; Lelièvre JD; Pantaleo G; Fenwick C; Centlivre M; Mouquet H; Cardinaud S; Zurawski SM; Zurawski G; Milpied P; Su L; Lévy Y
    PLoS Pathog; 2020 Nov; 16(11):e1009025. PubMed ID: 33253297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
    Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Model of the mIgM B-Cell Receptor Transmembrane Domain From Self-Association Molecular Dynamics Simulations.
    Friess MD; Pluhackova K; Böckmann RA
    Front Immunol; 2018; 9():2947. PubMed ID: 30619307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nanoscale spatial organization of B-cell receptors on immunoglobulin M- and G-expressing human B-cells.
    Lee J; Sengupta P; Brzostowski J; Lippincott-Schwartz J; Pierce SK
    Mol Biol Cell; 2017 Feb; 28(4):511-523. PubMed ID: 27974642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular requirements of the B-cell antigen receptor for sensing monovalent antigens.
    Volkmann C; Brings N; Becker M; Hobeika E; Yang J; Reth M
    EMBO J; 2016 Nov; 35(21):2371-2381. PubMed ID: 27634959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates.
    Ota T; Doyle-Cooper C; Cooper AB; Doores KJ; Aoki-Ota M; Le K; Schief WR; Wyatt RT; Burton DR; Nemazee D
    J Immunol; 2013 Sep; 191(6):3179-85. PubMed ID: 23940273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.
    Dennis M; Eudailey J; Pollara J; McMillan AS; Cronin KD; Saha PT; Curtis AD; Hudgens MG; Fouda GG; Ferrari G; Alam M; Van Rompay KKA; De Paris K; Permar S; Shen X
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
    Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
    PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV B Cell lines as candidate vaccine biosensors.
    Ota T; Doyle-Cooper C; Cooper AB; Huber M; Falkowska E; Doores KJ; Hangartner L; Le K; Sok D; Jardine J; Lifson J; Wu X; Mascola JR; Poignard P; Binley JM; Chakrabarti BK; Schief WR; Wyatt RT; Burton DR; Nemazee D
    J Immunol; 2012 Nov; 189(10):4816-24. PubMed ID: 23066156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.
    Astronomo RD; Santra S; Ballweber-Fleming L; Westerberg KG; Mach L; Hensley-McBain T; Sutherland L; Mildenberg B; Morton G; Yates NL; Mize GJ; Pollara J; Hladik F; Ochsenbauer C; Denny TN; Warrier R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Ferrari G; Shaw GM; Xia SM; Liao HX; Montefiori DC; Tomaras GD; Haynes BF; McElrath JM
    EBioMedicine; 2016 Dec; 14():97-111. PubMed ID: 27919754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.
    McGuire AT; Dreyer AM; Carbonetti S; Lippy A; Glenn J; Scheid JF; Mouquet H; Stamatatos L
    Science; 2014 Dec; 346(6215):1380-1383. PubMed ID: 25504724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation.
    Maity PC; Blount A; Jumaa H; Ronneberger O; Lillemeier BF; Reth M
    Sci Signal; 2015 Sep; 8(394):ra93. PubMed ID: 26373673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.